Epidemiology & Risk Factors

  • Severe psychological trauma: Strongest association with chronic childhood physical, sexual, or emotional abuse/neglect (> 90% in DID). c
  • Female predominance: Significantly higher in females for Dissociative Identity Disorder (DID).
  • Comorbidities: High rates of PTSD, Borderline Personality Disorder (BPD), Major Depressive Disorder (MDD), somatic symptom disorders, and substance use disorders.

Clinical Features

  • Depersonalization / Derealization Disorder:
    • Depersonalization: Persistent or recurrent feeling of detachment from one’s own body, mind, or actions (e.g., “out-of-body experience”, feeling like an automaton/robot).
    • Derealization: Persistent or recurrent feeling of detachment from surroundings; environment feels dreamlike, foggy, artificial, or lifeless.
    • Intact reality testing: Pt recognizes that these perceptions are not literal reality (differentiates from psychosis).
  • Dissociative Amnesia: c
    • Inability to recall important personal/autobiographical information, usually of a traumatic or stressful nature (inconsistent with ordinary forgetfulness).
    • Dissociative Fugue (Specifier): Sudden, unexpected purposeful travel or bewildered wandering associated with amnesia for identity or past autobiographical details.
  • Dissociative Identity Disorder (DID):
    • Disruption of identity characterized by ≥ 2 distinct personality states (“alters”) with marked discontinuity in sense of self and agency.
    • Recurrent gaps in recall of everyday events, important personal info, and/or past trauma.
    • Sudden changes in behavior, voice, affect, and preferences observed by others or reported by pt.

Diagnosis

  • Initial Workup / Rule-out (Exclusionary Testing):
    • Labs: Urine toxicology screen (UTox), serum EtOH, BMP, LFTs, TSH, Vit B12 (r/o substance/medication-induced states or metabolic encephalopathy).
    • EEG: Essential to r/o temporal lobe epilepsy (TLE), non-convulsive status epilepticus, or transient epileptic amnesia.
    • Brain MRI: Indicated if focal neurological deficits, atypical age of onset, or head trauma history (r/o mass, structural lesion, stroke).
  • Confirmatory:
    • Detailed psychiatric evaluation utilizing DSM-5 criteria.
    • Specialized diagnostic interviews (e.g., Structured Clinical Interview for DSM-5 Dissociative Disorders [SCID-D]).

Differential Diagnostics

  • Psychotic Disorders (e.g., Schizophrenia):
    • Diff: Psychosis involves loss of reality testing, fixed delusions, and true auditory hallucinations perceived externally. Depersonalization/derealization maintains intact reality testing.
  • Post-Traumatic Stress Disorder (PTSD):
    • Diff: While PTSD features dissociative symptoms, it is characterized by intrusion symptoms (flashbacks, nightmares), hyperarousal, and persistent avoidance of trauma reminders.
  • Borderline Personality Disorder (BPD):
    • Diff: BPD presents with affective instability, fear of abandonment, and transient stress-related dissociation, but lacks distinct, stable alter identities or massive autobiographical memory loss.
  • Transient Global Amnesia (TGA):
    • Diff: Sudden-onset anterograde amnesia lasting < 24 hours with preserved autobiographical identity and repetitive questioning; occurs in older pts (> 50 yo), not linked to trauma.
  • Malingering / Factitious Disorder:
    • Diff: Malingering involves intentional production of symptoms for secondary gain (financial, legal avoidance, drugs). Symptoms are typically exaggerated, stereotypical, and lack subtle dissociative signs.

Management

  • First-Line (Primary Modality):
    • Psychotherapy:
      • Depersonalization/Derealization: Cognitive Behavioral Therapy (CBT), psychodynamic therapy.
      • Dissociative Amnesia: Supportive psychotherapy, CBT, trauma-focused therapy; hypnosis used cautiously for memory retrieval.
      • DID: Long-term trauma-focused psychotherapy (phase-oriented: safety/stabilization -> processing trauma -> integration/harmony of identities).
  • Second-Line / Adjunctive (Pharmacotherapy):
    • No FDA-approved medications for dissociative disorders directly.
    • SSRIs / SNRIs: Target comorbid conditions (MDD, PTSD, anxiety).
    • Avoid Benzodiazepines: Can worsen dissociation, disinhibition, and memory impairment.
  • Crisis / Refractory:
    • Inpatient psychiatric hospitalization for severe dissociative states with acute suicidality or severe self-harm.

Complications

  • Suicidality & Self-Harm: High risk (> 70% of outpatients with DID attempt suicide; frequent non-suicidal self-injury [NSSI]).
  • Substance Use Disorder: Secondary self-medication for trauma and dissociative episodes.
  • Severe Functional Impairment: Occupational disability, relationship breakdowns, and chronic re-victimization.